{
    "Orphapacket": {
        "ORPHApacketId": "79168",
        "creationDate": "2022-06-14 15:58:09",
        "version": "1.3.16 / 4.1.7 [2022-01-26] (orientdb version)",
        "copyright": "Orphanet (c) 2022",
        "ORPHAcode": "79168",
        "Label": "Disorder of bile acid synthesis",
        "PURL": "http://www.orpha.net/ORDO/Orphanet_79168",
        "DisorderType": {
            "value": "Category",
            "PURL": "http://www.orpha.net/ORDO/Orphanet_557495"
        },
        "TextSection": {
            "TextSectionType": "Definition",
            "Contents": "A group of sterol metabolism disorders due to enzyme deficiencies of bile acid synthesis (BAS) in infants children and adults with variable manifestations that include cholestasis neurological disease and fat malabsorption. Nine inborn errors have been described 7 of which lead to liver cholestasis."
        },
        "Parents": [
            {
                "Parent": [
                    {
                        "ORPHAcode": "79226",
                        "Label": "Sterol metabolism disorder"
                    }
                ]
            }
        ],
        "Childs": [
            {
                "Child": {
                    "Label": "Idiopathic malabsorption due to bile acid synthesis defects",
                    "ORPHAcode": "84065",
                    "Genes": "no data"
                }
            },
            {
                "Child": {
                    "Label": "Bile acid synthesis defect with cholestasis and malabsorption",
                    "ORPHAcode": "163631",
                    "Genes": "no data"
                }
            },
            {
                "Child": {
                    "Label": "Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency",
                    "ORPHAcode": "209902",
                    "Genes": [
                        {
                            "Gene": {
                                "Label": "cytochrome P450 family 7 subfamily A member 1",
                                "Symbol": "CYP7A1",
                                "ExternalReferences": [
                                    {
                                        "Source": "HGNC",
                                        "Reference": "2651"
                                    },
                                    {
                                        "Source": "OMIM",
                                        "Reference": "118455"
                                    }
                                ]
                            }
                        }
                    ]
                }
            }
        ],
        "Phenotypes": [
            {
                "Phenotype": {
                    "HPOId": "HP:0000662",
                    "HPOTerm": "Nyctalopia",
                    "HPOFrequency": "Occasional (29-5%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0000707",
                    "HPOTerm": "Abnormality of the nervous system",
                    "HPOFrequency": "Frequent (79-30%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0001080",
                    "HPOTerm": "Biliary tract abnormality",
                    "HPOFrequency": "Very frequent (99-80%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0001392",
                    "HPOTerm": "Abnormality of the liver",
                    "HPOFrequency": "Very frequent (99-80%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0001396",
                    "HPOTerm": "Cholestasis",
                    "HPOFrequency": "Very frequent (99-80%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0001892",
                    "HPOTerm": "Abnormal bleeding",
                    "HPOFrequency": "Frequent (79-30%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0002630",
                    "HPOTerm": "Fat malabsorption",
                    "HPOFrequency": "Very frequent (99-80%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0002748",
                    "HPOTerm": "Rickets",
                    "HPOFrequency": "Frequent (79-30%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0002910",
                    "HPOTerm": "Elevated hepatic transaminase",
                    "HPOFrequency": "Very frequent (99-80%)"
                }
            },
            {
                "Phenotype": {
                    "HPOId": "HP:0009830",
                    "HPOTerm": "Peripheral neuropathy",
                    "HPOFrequency": "Frequent (79-30%)"
                }
            }
        ],
        "Prevalences": {
            "Prevalence": [
                {
                    "Source": "European Medicines Agency[INST]",
                    "PrevalenceType": "Point prevalence",
                    "PrevalenceQualification": "Value and class",
                    "PrevalenceClass": "1-9 / 1 000 000",
                    "ValMoy": "0.6",
                    "PrevalenceGeographic": "Europe"
                }
            ]
        },
        "AverageAgeOfOnsets": {
            "AverageAgeOfOnset": [
                {
                    "value": "All ages"
                }
            ]
        }
    }
}